Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis

Qingyue Zeng(West China Medical Center of Sichuan University), Shuangqing Li(City University of Hong Kong), Hong Fan(Sichuan University), Xingyu Mu(Sichuan University), Yi Shi(Sichuan University), Jiao Xu(Sichuan University)
Frontiers in Endocrinology
October 16, 2023
10.3389/fendo.2023.1214334
Cited by 62

Related Papers

Inflammation mechanism and research progress of COPD
|Frontiers in Immunology|2024|159
Hypoxia-inducible transcription factor-1α promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway
|BMC Cancer|2006|78
Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic
|Frontiers in Medicine|2023|72
The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort
|Cardiovascular Diabetology|2024|59
Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
|Frontiers in Endocrinology|2021|56